Skip to main content
SpringerLink
Log in

Letter to the Editor

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Grill J, Kalifa C, Doz F, Schoepfer C, Sainte-Rose C, Couanet D, Terrier-Lacombe MJ, Valteau-Couanet D, Hartmann O: A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma: a phase-II study. Pediatr Neurosurg 25: 7-12, 1996

    PubMed  Google Scholar 

  2. Grill J, Kalifa C, Doz F, Demeocq C, Chastagner P, Le Deley MC, Valteau-Couanet D, Hartmann O, for the SFOP group: High-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood ependymoma: a phase II study of the French Society of Pediatric Oncology (SFOP) (abstract of the XXVIIth SIOP meeting in Montevideo). Med Ped Oncol 25: 304, 1995

    Google Scholar 

  3. Dupuis-Girod S, Hartmann O, Benhamou E, Doz F, Mechinaud F, Bouffet E, Coze C, Kalifa C: Will high-dose chemotherapy followed by autologous bone marrow transplantation supplant craniospinal irradiation in young children treated for medulloblastoma? J Neuro-Oncol 27: 87-98, 1996

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Letter to the Editor. J Neurooncol 40, 97 (1998). https://doi.org/10.1023/A:1017109414966

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1017109414966

Search

Navigation